PIQ 2.27% 90.0¢ proteomics international laboratories ltd

Ann: Proteomics International seeks FDA approval for PromarkerD, page-162

  1. 33 Posts.
    lightbulb Created with Sketch. 3
    Could somebody please do my maths:
    if we assume Invokana market share is US$668B and PD becomes a complementary test.. the income from the partnership with Jansen could be quite something.
    But I'm not smart enough to understand - If/How this be extrapolated..?
    I'm not sure on the number of tests required each year by each patient and if this can be measured directly against the cost of Invokana to project a future value of the company based at this point solely on its DKD Promarker D stuff..
 
watchlist Created with Sketch. Add PIQ (ASX) to my watchlist
(20min delay)
Last
90.0¢
Change
0.020(2.27%)
Mkt cap ! $117.9M
Open High Low Value Volume
90.5¢ 92.5¢ 87.0¢ $198.7K 220.8K

Buyers (Bids)

No. Vol. Price($)
1 4904 90.0¢
 

Sellers (Offers)

Price($) Vol. No.
92.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.